相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
Zaffar K. Haque et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload
Wei-ming Li et al.
CLINICAL SCIENCE (2017)
Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway
Rui Yang et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
Andrographolide Benefits Rheumatoid Arthritis via Inhibiting MAPK Pathways
Zun-zhong Li et al.
INFLAMMATION (2017)
Evodiamine attenuates TGF-β1-induced fibroblast activation and endothelial to mesenchymal transition
Qing-Qing Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Andrographolide inhibits arrhythmias and is cardioprotective in rabbits
Mengliu Zeng et al.
ONCOTARGET (2017)
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
Aditi Banerjee et al.
ONCOTARGET (2017)
Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
Chen-wei Pan et al.
ONCOTARGET (2017)
Mechanisms contributing to cardiac remodelling
Qing-Qing Wu et al.
CLINICAL SCIENCE (2017)
Myofibroblasts and inflammatory cells as players of cardiac fibrosis
Hitoshi Kurose et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Cardiac Fibrosis The Fibroblast Awakens
Joshua G. Travers et al.
CIRCULATION RESEARCH (2016)
OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells
Qing-Qing Wu et al.
CLINICAL SCIENCE (2016)
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice
Yuan Yuan et al.
HYPERTENSION (2016)
Andrographis paniculata extract attenuates pathological cardiac hypertrophy and apoptosis in high-fat diet fed mice
You-Liang Hsieh et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs)
Ruijie Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK
Siew Ying Wong et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Andrographolide stimulates p38 mitogen-activated protein kinase-nuclear factor erythroid-2-related factor 2-heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats
Ting-Lin Yen et al.
TRANSLATIONAL RESEARCH (2016)
Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways
Tingfang Yang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-κB pathways
Shuang Peng et al.
ACTA PHARMACEUTICA SINICA B (2016)
Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis
Mostafa Samak et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2016)
Andrographolide Ameliorates Abdominal Aortic Aneurysm Progression by Inhibiting Inflammatory Cell Infiltration through Downregulation of Cytokine and Integrin Expression
Jun Ren et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway
Qing-Qing Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-B signalling pathway
Yongmei Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Andrographolide Attenuates LPS-Induced Cardiac Malfunctions Through Inhibition of I kappa B Phosphorylation and Apoptosis in Mice
Jinlong Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Mechanotransduction in Cardiac Hypertrophy and Failure
Robert C. Lyon et al.
CIRCULATION RESEARCH (2015)
Cardiac Fibroblast Physiology and Pathology
David Dostal et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Bioavailability of andrographolide and protection against carbon tetrachloride-induced oxidative damage in rats
Haw-Wen Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Parsing Good Versus Bad Signaling Pathways in the Heart: Role of Calcineurin-Nuclear Factor of Activated T-Cells
Jeffery D. Molkentin
CIRCULATION RESEARCH (2013)
Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice
Tamara P. Martin et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II
Feifei Ma et al.
PLOS ONE (2012)
Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets
Jianglong Hou et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Cardiac remodeling at the population level -risk factors, screening, and outcomes
Ola Gjesdal et al.
NATURE REVIEWS CARDIOLOGY (2011)
Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
Heng Zhou et al.
PLOS ONE (2011)
Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
Izhak Kehat et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts
Xiuren Gao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation
Maria D. Carretta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Kristina Lorenz et al.
NATURE MEDICINE (2009)
Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury
Anthony Y. H. Woo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HPLC determination of andrographolide in rat whole blood: study on the pharmacokinetics of andrographolide incorporated in liposomes and tablets
Xu-Bin Suo et al.
BIOMEDICAL CHROMATOGRAPHY (2007)
Andrographolide inhibits IFN-γ and IL-2 cytokine production and protects against cell apoptosis
RA Burgos et al.
PLANTA MEDICA (2005)
Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects
BG Petrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models
QR Liang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Myofibroblasts and mechano-regulation of connective tissue remodelling
JJ Tomasek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
P Liao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
